BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 13, 2002
View Archived Issues
Telomerase inhibitors under study at Pharmacia
Read More
Novel 5-HT6 ligands for depression, anxiety, cognitive disorders, etc., claimed in recent patent
Read More
AstraZeneca team identifies kappa opioid agonists
Read More
TLK-286 enters two new combination trials
Read More
Amended phase II protocol for FM-VP4
Read More
Argenta Discovery and Amedis extend collaboration
Read More
Provectus acquires company recently split from Photogen
Read More
Milnacipran improves FMS pain and fatigue in preliminary analysis
Read More
Phase III Ampligen trial in CFS completes enrollment
Read More
Paladin returns Canadian DepoCyt rights to SkyePharma
Read More
Pharmexa and Lundbeck Alzheimer's collaboration achieves proof of concept in animals
Read More
Minimal toxicity reported for SGN-30 in Hodgkin's disease and lymphoma
Read More
Potential use of MLN-518 in AML and high-risk MDS
Read More
Significant improvement reported on eculizumab in patients with paroxysmal nocturnal hemoglobinuria
Read More
Reduced liver iron content in thalassemic patients treated with ICL-670
Read More
Comparison of warfarin and idraparinux sodium in deep vein thrombosis
Read More
New cephem antibiotics discovered jointly by Fujisawa and Wakunaga
Read More
Series of 5-HT1A antagonists in early development at Wyeth
Read More
KuDOS and Maybridge claim isoquinoline-based PARP inhibitors
Read More
New tyrosine kinase inhibitors and their use in proliferative disorders
Read More
Veronate granted fast track status
Read More
Helix BioPharma completes acquisition of minority interest in Sensium
Read More
Medicure enters research collaboration with university group for NHE inhibitors
Read More
GSK identifies novel 5-HT7 receptor antagonist with good pharmacokinetic properties
Read More
Fully human MAb to human VEGFR-3 designed at ImClone Systems
Read More
Pharmacological profile of VX-944, an IMPDH inhibitor, characterized at ASH meeting
Read More
